Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance.
about
Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasisCirculating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and reviewRoles of miR-182 in sensory organ development and cancerAlterations of the TP53 gene in gastric and esophageal carcinogenesisRole of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancerKey nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancerA Downmodulated MicroRNA Profiling in Patients with Gastric Cancer.MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2.Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancerMiRNA as potential biomarkers and therapeutic targets for gastric cancer.MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways.MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factorThe role of microRNA-133b and its target gene FSCN1 in gastric cancer.A systematic review of microRNA expression profiling studies in human gastric cancer.MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer.Analysis of plasma MicroRNAs to identifying early diagnostic molecule for gastric cancer.Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer.The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.microRNA analysis of gastric cancer patients from Saudi Arabian population.miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cellsDownregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation.Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy.Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma.Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the β-Catenin/TCF/LEF-1 pathway in gastric cancer cells.Identification of Aberrantly Expressed miRNAs in Gastric Cancer.Understanding the CREB1-miRNA feedback loop in human malignancies.MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2.miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer.Evaluation of altered expression of miR-9 and miR-106a as an early diagnostic approach in gastric cancer.Proposed Molecular and miRNA Classification of Gastric Cancer.miR-18a-5p promotes cell invasion and migration of osteosarcoma by directly targeting IRF2
P2860
Q26747871-84819748-E4B7-4BE5-8BD6-722E03DE008FQ26785539-BC0C9CE7-1D56-44F2-B811-2267709D039BQ26798264-93F60C7A-6B19-42DB-BCA7-63F71869EF7FQ26866191-5D95EA59-25A3-4D6E-82D3-53723E5AD33CQ28067449-0FAFEC52-313F-4A28-833A-AFB77D3A79DFQ28082679-0766D5FC-EDE6-4367-AFC9-A61F505E8885Q33701796-2B097539-3F26-452C-9F30-222159A68C34Q33709860-03BF02FB-7022-4612-A70A-0F03FF262D83Q33913929-5586FE8F-2749-4ED6-B1F8-25AAA59D7CF0Q34036679-1A4F6394-5389-4A6B-B4FC-B78F8A22F2DCQ34571491-3402D1AD-BC0B-4546-B80A-E8B62CFA4C7BQ34579942-FAA3A569-32A1-4F0D-AC58-65CE03BB76ADQ34748529-0DC184CD-DD5F-4851-A582-96F5D70064FAQ35000434-21A908E7-149A-4722-97B9-121A0C4046D7Q35051479-F5EF9D7D-2AA4-4169-A637-D8B672B3E45FQ35643666-7F7A8683-908A-464D-BFF8-98FD0E6EAD9BQ35690791-8B1F30E9-2886-4607-BF16-405D2EB2CD68Q36158807-8E90B129-53D2-4B54-B35D-2CDE7F1B7998Q36170351-BE31A3A8-1B24-4641-AF88-603F6E2EE9EBQ36199659-8D1F94A3-B0BC-4C07-BFC6-D2EB4798274CQ36224976-CD28BCCA-172A-4986-ACF6-4570DDD452ADQ36264911-AB978618-057C-4005-9D21-E526DC511746Q36695308-CA5A752A-DF50-4E20-B3BF-BBF07099DA0BQ37631794-4A41F5D2-1F6C-4080-94AD-8DD8E92314C4Q38475359-8B9239D1-B3B1-4A35-8EDA-FC0FB408427CQ38802458-142FECE4-A329-4B31-AFC0-AD19807E1768Q39016583-163A05FF-B7A0-4FB5-9A2B-7936518D3068Q47126089-10850209-B052-47A5-AD51-93D788535E80Q53176896-A3CE8436-850E-4C3F-911A-17270ACDEE16Q55603677-A1307C03-C03F-4647-AF8A-5E6456559492Q57165706-342A139A-F9C2-4B84-A097-E245A5E63036
P2860
Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of new aberrant ...... and its clinical significance.
@ast
Identification of new aberrant ...... and its clinical significance.
@en
Identification of new aberrant ...... and its clinical significance.
@nl
type
label
Identification of new aberrant ...... and its clinical significance.
@ast
Identification of new aberrant ...... and its clinical significance.
@en
Identification of new aberrant ...... and its clinical significance.
@nl
prefLabel
Identification of new aberrant ...... and its clinical significance.
@ast
Identification of new aberrant ...... and its clinical significance.
@en
Identification of new aberrant ...... and its clinical significance.
@nl
P2093
P356
P1433
P1476
Identification of new aberrant ...... and its clinical significance.
@en
P2093
Deyun Feng
Feijun Luo
Guiying Zhang
P304
P356
10.3892/OR.2011.1437
P577
2011-08-24T00:00:00Z